Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    The future of the robotics metaverse in the healthcare sector

    On February 26, 2025, the European Economic and Social Committee (EESC) adopted an opinion addressing the integration of robotics and the metaverse in healthcare.
    United StatesFood, Drugs, Healthcare, Life Sciences
    A&O Shearman
    A&O Shearman
  • Article

    The Quid Pro Quo Failing Biodiversity And The Discovery Of New Products

    WilmerHale Partner Bruce Manheim has written an opinion piece that was published in the journal BioScience, volume 69, issue 11, November 2019, pages 856–857.
    United StatesFood, Drugs, Healthcare, Life Sciences
    WilmerHale
    WilmerHale
Article

They Did It! A Rotating Nanotechnology Motor That Runs On Electric Current

At Tufts University there now exists the worlds smallest electric motor.
United StatesFood, Drugs, Healthcare, Life Sciences
Day Pitney LLP
Day Pitney LLP
  • Article

    To Dance Or Not To Dance: Biosimilar Strategies Post Amgen V Sandoz

    The Biologics Price Competition and Innovation Act (BPCIA) is a landmark piece of legislation signed into law by the Obama administration in 2009.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    Trendspotting 2023: Key Policies That May Impact The Life Sciences Industry

    On January 3, the federal government opened the 118th Congress – a group that will undoubtedly have a significant influence over the future of the life sciences industry over the next several years.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Ultragenyx’s FAYUVI Becomes First FDA-Approved Treatment for Sanfilippo Syndrome Type A

    Ultragenyx Pharmaceutical has received FDA approval for FAYUVI, a groundbreaking one-time gene therapy designed to halt or slow the progression of mucopolysaccharidosis type IIIA (MPS IIIA), also known as Sanfilippo syndrome type A. This marks the first-ever treatment capable of addressing the underlying cause of this ultra-rare, fatal neurodegenerative disorder that has previously had no disease-modifying therapeutic options.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Unveiling The Latest Industry Mergers And Acquisitions

    Ankura is pleased to present an overview of healthcare transactions announced or closed during Q2 2023 in the United States.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Ankura Consulting Group LLC
    Ankura Consulting Group LLC
  • Article

    Upcoming FDA Public Meeting On Speech And Medical Products

    As a reminder, the Food and Drug Administration (FDA) is holding a two-day public meeting on November 9 and 10, 2016 regarding "Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Update On Celltrion's Infliximab Biosimilar

    Celltrion recently confirmed that it proved the effectiveness of its subcutaneous infliximab biosimilar, RemsimaSC (CT-P13 SC) in two global Phase III trials.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    UPDATE: Pacira Pharmaceutical Inc. v. FDA Lawsuit Settled

    The Pacira Pharmaceutical Inc. v. FDA lawsuit has been a frequent topic of discussion on the blog, and now, in breaking news, the case has been settled.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    Updates With Materials Genome Initiative, $25M Grants Announced; Complex IP Issues?

    The Office of Science and Technology Policy (OSTP) recently announced updates with the Materials Genonme Initiative (MGI). $25M in grants are noted, and the awardees include universities, national laboratories, and private sector companies (e.g., GM). Collaboration continues to be a strong theme.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    U.S. Congressional Committees Address Drug And Device Approval

    As mentioned on our Health Industry Washington Watch blog, committees in both the House of Representatives and Senate last week addressed the speed at which medical innovations are approved and available for patient use.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    U.S. Patent Office Issues Guidance To Examiners On Supreme Court's Myriad Decision

    The USPTO recently issued guidance to Examiners on how to apply the Myriad Supreme Court decision to applications under examination.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    USC Announces Stem Cell Collaboration

    Treatment and prevention of heart failure are unmet medical needs in the United States. One in every eight deaths in the United States can be linked to this disease.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    USDA Withdraws Proposed Rule On Sharing GMO Business Information With States

    USDA withdrew a proposed rule that would have amended its regulations regarding GMOs to add provisions for sharing certain business information.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    USPTO Imposes New Limits On Credit Card Payments

    As announced on the USPTO website, as of June 30, 2012, there will be a daily limit of $49,999.99 for credit card accounts, but no daily limit for debit card accounts.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    Vaccine Readiness, Preparing Your Company For Vaccines And Avoiding Employee Claims - Webinar Recording

    my Miller, shareholder in the Litigation section and co-head of the firm's Washington, D.C. office and Barbara Binzak Blumenfeld, shareholder in the firm's Life Sciences Industry Group, presented a...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Venable's BiologicsHQ Monthly Injection – September 2023

    Venable's BiologicsHQ Monthly Injection – September 2023
    United StatesFood, Drugs, Healthcare, Life Sciences
    Venable LLP
    Venable LLP
  • Article

    Wilmerhale Reps Nantero In $21M Financing For Carbon Nanotube Computer Memory

    Nantero Inc., the nanotechnology company developing next-generation memory using carbon nanotubes, announced the closing of more than $21 million financing round.
    United StatesFood, Drugs, Healthcare, Life Sciences
    WilmerHale
    WilmerHale
  • Article

    With The Statutory Deadline Approaching, FDA Issues A Proposed Sunscreens Rule

    With the statutory deadline approaching, FDA issues a proposed sunscreens rule.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Hogan Lovells
    Hogan Lovells
  • Showing 561–580 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics